Literature DB >> 2620461

Perifusion of human granulosa-luteal cells: response to LH stimulation.

T J Weiss1, P A Steele, K Umapathysivam.   

Abstract

LH pulse frequency and amplitude vary significantly during the menstrual cycle; however, it is not clear what significance the secretory pattern has for the ovary. We have developed an in-vitro perifusion system in which luteinized human granulosa cells (GC) can be exposed to various patterns of gonadotrophin stimulation. GC were recovered following follicle aspiration for in-vitro fertilization, grown on Cytodex-3 for 6 days, and then perifused with medium containing LH (or hCG), delivered with differing pulse frequencies and amplitudes. When pulses of LH were applied to the cells, progesterone secretion rose initially and then fell to the baseline as the LH concentration declined. Pulsatile administration of LH, over a period of 10 h, stimulated progesterone secretion more efficiently than did continuous LH. Finally, delivery to the cells of pulses of hCG, a ligand known to bind to the LH receptor but with binding characteristics distinct from those of LH, failed to elicit pulses of progesterone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620461     DOI: 10.1111/j.1365-2265.1989.tb01252.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  The common genetic variant of luteinizing hormone has a longer serum half-life than the wild type in heterozygous women.

Authors:  Leif Wide; Karin Eriksson; Patrick M Sluss; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2009-11-04       Impact factor: 5.958

3.  Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women.

Authors:  Leif Wide; Karin Eriksson; Patrick M Sluss; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.